We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Ampronix,  Inc

Download Mobile App




Illustration

Pfizer and BioNTech to Supply Japan with 120 Million Doses of mRNA-Based COVID-19 Vaccine

Pfizer Inc. (New York, NY, USA) and Biopharmaceutical New Technologies (BioNTech Mainz, Germany) have entered into an agreement with Japan to supply 120 million doses of its BNT162 mRNA-based vaccine candidate against SARS-CoV2. More...
04 Aug 2020
Illustration

Applied DNA’s COVID-19 Diagnostic Kit Granted FDA EUA Amendment for Use on Widely Installed RT-PCR Device and High-Throughput RNA Extraction Robotics

Applied DNA Sciences Inc. (Stony Brook, NY, USA) has been granted Emergency Use Authorization (EUA) amendment by the US Food and Drug Administration (FDA) that expands the installed base of PCR equipment platforms which can process the company’s Linea COVID-19 Assay Kit and introduces automation to significantly increase the throughput of the assay by use of robotic RNA extraction. More...
03 Aug 2020
Image: Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3 (Photo courtesy of Merck)

Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3

Merck (Kenilworth, NJ, USA) has announced that it is accelerating its COVID-19 vaccine development efforts and plans to begin clinical studies of its first vaccine candidate in the third quarter of this year. More...
03 Aug 2020
Image: Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2 (Photo courtesy of Medical College of Georgia at Augusta University)

Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2

A team of researchers have developed a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples that could have a significant impact on large-scale population screening in the wake of the current COVID-19 pandemic. More...
03 Aug 2020
Image: SARS-CoV-2 RT-PCR diagnostics test (Photo courtesy of Maccura Biotechnology)

Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test

Diazyme Laboratories, Inc. (Poway, CA, USA) has entered into a partnership with Maccura Biotechnology (Sichuan, China) for the launch of a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. More...
03 Aug 2020
Illustration

US FDA Authorizes First Tests from Siemens That Estimate Antibodies from Past COVID-19 Infections

The US Food and Drug Administration has authorized the first two COVID-19 serology tests that display an estimated quantity of antibodies present in an individual’s blood. More...
03 Aug 2020
Image: New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time (Photo courtesy of FSVO/Renate Boss)

New Rapid Test Determines Amount of Neutralizing Antibodies Against SARS-CoV-2 Within Short Period of Time

A Swiss-German team of researchers have developed a test that determines the amount of neutralizing antibodies against SARS-CoV-2 within a short period of time. More...
03 Aug 2020
Copyright © 2000-2020 Globetech Media. All rights reserved.